Bio-Connect
ICC/IF analysis of HeLa cells using GTX80164 AHNAK antibody [EM-09]. Red : Primary antibody Blue : DAPI
ICC/IF analysis of HeLa cells using GTX80164 AHNAK antibody [EM-09]. Red : Primary antibody Blue : DAPI
ICC/IF analysis of HeLa cells using GTX80164 AHNAK antibody [EM-09]. Red : Primary antibody Blue : DAPI

AHNAK antibody [EM-09]

GTX80164
GeneTex
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
Product group Antibodies
TargetAHNAK
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    AHNAK antibody [EM-09]
  • Delivery Days Customer
    9
  • Applications
    ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    EM-09
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID79026
  • Target name
    AHNAK
  • Target description
    AHNAK nucleoprotein
  • Target synonyms
    AHNAK1, AHNAKRS, PM227, neuroblast differentiation-associated protein AHNAK, AHNAK-related, desmoyokin
  • Host
    Mouse
  • Isotype
    IgG1
  • Protein IDQ09666
  • Protein Name
    Neuroblast differentiation-associated protein AHNAK
  • Scientific Description
    The protein encoded by this gene is a large (700 kDa) structural scaffold protein consisting of a central domain with 128 aa repeats. The encoded protein may play a role in such diverse processes as blood-brain barrier formation, cell structure and migration, cardiac calcium channel regulation, and tumor metastasis. A much shorter variant encoding a 17 kDa isoform exists for this gene, and the shorter isoform initiates a feedback loop that regulates alternative splicing of this gene. [provided by RefSeq, Oct 2016]
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.
    Read more